Allegis Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$1.04M Sell
8,120
-62
-0.8% -$8.38K 0.32% 74
2017
Q4
$1.14M Sell
8,182
-2,162
-21% -$301K 0.34% 85
2017
Q3
$1.34M Buy
10,344
+90
+0.9% +$11.9K 0.32% 86
2017
Q2
$1.36M Buy
10,254
+2,247
+28% +$287K 0.34% 88
2017
Q1
$997K Buy
8,007
+1,008
+14% +$120K 0.26% 94
2016
Q4
$806K Sell
6,999
-570
-8% -$65.8K 0.25% 106
2016
Q3
$894K Sell
7,569
-1,842
-20% -$223K 0.35% 93
2016
Q2
$1.12M Buy
9,411
+204
+2% +$23.2K 0.56% 65
2016
Q1
$996K Buy
9,207
+43
+0.5% +$4.45K 0.57% 66
2015
Q4
$941K Buy
+9,164
New +$922K 0.53% 52

Other funds holding JNJ

Allegis Investment Advisors's JNJ Position: Q1 2018 in Review

Allegis Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 0.76% in Q1 2018, selling an estimated $8.38K and leaving 8,120 shares worth $1.04M. The position accounts for 0.32% of the portfolio, ranked #74.

Allegis Investment Advisors first reported a position in JNJ in Q4 2015 and has held it in 10 quarters since. The position peaked at $1.36M in Q2 2017. 2,598 funds tracked by Wall St. Rank hold JNJ as of Q1 2018.

  • Allegis Investment Advisors held 8,120 shares of Johnson & Johnson worth $1.04M as of Q1 2018.
  • Allegis Investment Advisors sold 62 Johnson & Johnson shares in Q1 2018, an estimated $8.38K.
  • Johnson & Johnson made up 0.32% of Allegis Investment Advisors's portfolio in Q1 2018, its #74 holding.
  • Allegis Investment Advisors first reported a position in Johnson & Johnson in Q4 2015 and has held it in 10 quarters since.
  • Allegis Investment Advisors's Johnson & Johnson position peaked at $1.36M in Q2 2017.
  • 2,598 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2018.

Based on Allegis Investment Advisors's 13F filing for Q1 2018, filed 24 Apr 2018.